The bone morphogenetic protein (BMP) signaling pathway comprises multiple ligands and receptors that interact promiscuously with one another and typically appear in combinations. This feature is often explained in terms of redundancy and regulatory flexibility, but it has remained unclear what signal-processing capabilities it provides. Here, we show that the BMP pathway processes multi-ligand inputs using a specific repertoire of computations, including ratiometric sensing, balance detection, and imbalance detection. These computations operate on the relative levels of different ligands and can arise directly from competitive receptor-ligand interactions. Furthermore, cells can select different computations to perform on the same ligand combination through expression of alternative sets of receptor variants. These results provide a direct signal-processing role for promiscuous receptor-ligand interactions and establish operational principles for quantitatively controlling cells with BMP ligands. Similar principles could apply to other promiscuous signaling pathways.
INTRODUCTION
Many intercellular signaling pathways, such as bone morphogenetic protein (BMP), Wnt, Notch, and JAK-STAT, exhibit a curious feature. Rather than using a single ligand and receptor, these systems comprise multiple ligand and receptor variants that interact promiscuously with one another to combinatorially generate a large set of distinct signaling complexes. These complexes activate the same intracellular targets and therefore appear to operate redundantly. Previous work has suggested that the use of redundant ligands and receptors offers regulatory flexibility (Llimargas and Lawrence, 2001) or provides robustness to genetic variation (Dudley and Robertson, 1997; Edson et al., 2010) . However, it is also possible that this apparent redundancy provides specific signal-processing capabilities (Mueller and Nickel, 2012; Murray, 2007; Schmierer and Hill, 2007; Wodarz and Nusse, 1998) .
The BMP pathway is an ideal example of promiscuous receptor-ligand architecture ( Figure 1A) . In mammalian species, it includes more than 20 distinct ligands, 4 type I receptors (BMPR1A, BMPR1B, ACVR1, and ALK1), and 3 type II receptors (BMPR2, ACVR2A, and ACVR2B). These components could interact combinatorially to form hundreds of distinct receptorligand signaling complexes, each composed of 2 type I and 2 type II receptors binding a dimeric ligand. Active signaling complexes phosphorylate SMAD1, 5, and 8, which, together with SMAD4, translocate to the nucleus to regulate target gene expression (Heldin et al., 1997; Massagué , 1998) .
Two features of the BMP pathway suggest the possibility of more complex signal processing. First, in most contexts, multiple BMP ligands and receptors appear in overlapping spatiotemporal distributions and therefore appear to be utilized in combinations (Danesh et al., 2009; Faber et al., 2002; LordaDiez et al., 2014; Salazar et al., 2016) . For example, BMP9 and BMP10 co-regulate the formation of vasculature (Chen et al., 2013; Ricard et al., 2012) , while BMP2, BMP4, GDF5, and GDF6 operate together in joint development (Storm and Kingsley, 1996) . Similarly, at least 6 distinct ligands and 3 receptors are involved in kidney development (Simic and Vukicevic, 2005) . Second, individual ligands preferentially signal through particular receptors. For example, ALK1 is preferentially activated by BMP9 and BMP10 in endothelial cells (David et al., 2007) ; GDF5 signals mainly through BMPR1B and not BMPR1A (Nishitoh et al., 1996) ; and BMP2/4 and BMP6/7 signal through distinct receptors to induce mesenchymal stem cell differentiation (Lavery et al., 2008) .
The ability to form many competing complexes with distinct affinity and activity preferences could, in principle, allow the system to perform complex signal processing. However, we lack a general quantitative framework to understand how the BMP pathway perceives combinations of ligands, how such combinatorial perception emerges from underlying molecular interactions, and whether and how distinct cell types respond differently to the same ligand combinations.
Here, combining theoretical and experimental approaches, we show that the BMP pathway perceives ligand combinations through a specific family of multi-dimensional response profiles. These profiles allow the pathway to perceive relative, in addition to absolute, levels of multiple ligands. Mathematical modeling further reveals that these response profiles can arise from interplay between receptor-ligand binding affinities and the quantitative activity of each complex. The former determine what complexes are formed, while the latter determines how the activities of those complexes combine to establish overall pathway activity. Critically, we find that the response profiles differ qualitatively and quantitatively depending on the expression levels of the different receptor variants. As a result, different cell types, with distinct receptor expression profiles, can respond to distinct features in the multidimensional space of ligand concentrations. Together, these results establish a general framework for analyzing the BMP signaling pathway and reveal a more general design principle for biological signaling systems containing promiscuous receptor-ligand interactions.
RESULTS

Theoretical Framework
To analyze the way in which the BMP pathway uses multiple receptor variants to integrate signals from multiple dimeric ligand species, it is useful to consider two multi-dimensional spaces. Cellular environments, specified by the concentrations of each of the dimeric ligand species, can be represented as points in a multi-dimensional ''ligand space'' ( Figure 1B ). Similarly, individual cell types typically co-express multiple type I and type II receptors (Cheifetz, 1999) and can therefore be represented as points in a 7-dimensional ''receptor space'' specified by the individual expression levels of each receptor ( Figure 1C ). (This space is, more precisely, the combination of a 3-dimensional space for the type I receptors and a 4-dimensional space for the type II receptors.) Not every point in ligand or receptor space may be realized biologically, and other secreted and intracellular factors further modulate BMP signaling in specific contexts (Balemans and Van Hul, 2002; Zakin and De Robertis, 2010) . Nevertheless, understanding signal processing by the BMP pathway requires determining how multiple ligands combine, or integrate, to control the pathway activity in a cell with a given receptor configuration ( Figure 1D ) and whether distinct cells, expressing specific combinations of receptors, can integrate the same ligands in qualitatively different ways ( Figure 1E ).
BMP Ligands Exhibit Combinatorial Effects
In order to address these questions experimentally, we set out to measure the dependence of BMP pathway activity on individual ligands and ligand combinations. Ligand monomers form covalent homodimers and heterodimers with distinct activities (Israel et al., 1996; Neugebauer et al., 2015; Valera et al., 2010) . Here, we focused on mixtures of distinct homodimeric ligands, which have been shown to produce non-additive responses in some systems (Ying et al., 2000 (Ying et al., , 2001 Ying and Zhao, 2001; Aç il et al., 2014) . Mixtures of heterodimeric ligands could be analyzed similarly.
To quantitatively measure BMP pathway activity, we constructed a reporter cell line by stably integrating a histone 2B (H2B)-Citrine fluorescent reporter driven by a BMP response element (BRE) specific for SMAD1/5/8 (Korchynskyi and ten Dijke, 2002) into the NAMRU mouse mammary gland (NMuMG) epithelial cell line, in which the BMP pathway can be activated without inducing differentiation (Piek et al., 1999) . Reporter expression correlated with phosphorylation of SMAD1/5/8 and with endogenous BMP target gene expression (Figures S1A-S1C) and exhibited a unimodal distribution for each ligand concentration ( Figure S1D ). After an elevated transient response to BMP addition, pSMAD levels reached a steady state within 90 min ( Figure S1E ). The steady-state behavior was also reflected in reporter fluorescence, which accumulated at an approximately constant rate over time for up to 48 hr ( Figure S1F ). . (D and E) These representations provoke the questions of how multiple ligands combine to determine pathway activity in a given cell type (D) and how different cell types respond to the same ligand combination (E) .
(Since the fluorescent protein is stable and the cell cycle is longer than 24 hr in these conditions, linear accumulation indicates a constant rate of reporter expression.) Based on these dynamics, we selected 24 hr post induction as a time point for subsequent analysis.
As a first step to classifying ligand integration behaviors, we sought to identify candidate ligand pairs for subsequent higher-resolution analysis. We performed a coarse-grained survey of 15 commercially available homodimeric ligands ( Figure 2A ). We measured reporter expression in response to each ligand individually, at a specific base concentration (STAR Methods; Table S1 ); each ligand at twice its base concentration (diagonal elements); and each pair of ligands at their base concentrations (other matrix elements). To quantify pathway activity, we normalized each measurement by basal activity with no added ligand (bottom).
Many individual ligand pairs generated stronger or weaker responses than expected given their individual effects (Figures 2A, S1G, and S1H) . For example, BMP3 combined antagonistically with almost every other ligand. Furthermore, some individual ligands combined in qualitatively different ways with different ligands. For example, BMP7 and BMP4 each exhibited a mixture of antagonistic and synergistic interactions with other ligands. Overall, these results indicate that the effect of any given ligand on pathway activity can, in general, depend in complex ways on other ligands. Relative Activity
Relative Activity Relative Activity (B) From the complete interaction matrix, we extracted the individual response to each ligand (top row) and compared to the response to BMP4 (bottom row) and to mixtures of each ligand with BMP4 (middle row). By comparing each vertical triplet, we see that specific ligands combine with BMP4 in different ways, both synergistically and antagonistically. (C-E) Measurements of full input-output response profiles for specific ligand pairs. BMP4 and BMP9 combine to increase pathway activity in an additive fashion (C) . BMP4 and GDF5 combine in a ratiometric manner (D) . BMP4 and BMP10 showed an ''imbalance detection'' response (E) . For each plot in (C-E) , the dashed outline indicates a set of ligand concentrations varying from high concentration of one ligand (top left corner) to high concentration of the other ligand through intermediate states containing both ligands (e.g., top right). In (C-E) , the bottom row and left column correspond to an absence of the indicated ligand. (F-H) The responses along the dashed contour are plotted for BMP4-BMP9 (F), BMP4-GDF5 (G), and BMP4-BMP10 (H). Each pair shows a different dependence on ligand ratio. The logarithmic levels of each ligand are indicated schematically by the heights of the blue/green bars along the x axis. Error bars indicate SD calculated from at least 3 experiments. See also Figures S1 and S2 and Tables S1 and S4.
Higher-Resolution Analysis Reveals Distinct Multiligand Response Profiles
To gain a clearer view of multi-ligand responses, we analyzed the diverse ways in which BMP4, one of the best-studied BMP ligands, combines with other ligands (Figure 2B ), particularly BMP9, GDF5, and BMP10 ( Figures 2C-2E ). To quantitatively characterize these interactions in a manner independent of the choice of base concentrations, we analyzed a 2-dimensional matrix of logarithmically spaced ligand concentrations ( Figures  2C-2E ). The broad (3 orders of magnitude) concentration range covers the full input dynamic range for each ligand pair in the NMuMG cell line and overlaps ligand concentrations in circulating blood (David et al., 2008) , as well as those used to induce BMP-dependent responses in vitro (Lavery et al., 2008; Heggebö et al., 2014; Hatsell et al., 2015) .
Each of the three ligand pairs showed qualitatively distinct response profiles. BMP4 and BMP9 increased pathway activity both individually and in combination, exhibiting an additive response, with little dependence on ligand identity, as one would expect for ligands that function redundantly (Figures 2C and S2A) . By contrast, GDF5 reduced activation by BMP4 in a dose-dependent fashion, such that pathway output approximated the ratio of the concentrations of the two ligands ( Figures  2D and S2A ). Similar ratiometric responses have been observed in other systems (Atkinson, 1968; Berg et al., 2009; EscalanteChong et al., 2015; Madl and Herman, 1979) . Finally, and most intriguingly, BMP4 and BMP10 were potent activators individually, but each became inhibitory in the presence of high concentrations of the other ligand, resulting in a weaker response when both ligands were present (Figures 2E and S2A) . Interestingly, in this mode, each ligand can play both activating and inhibitory roles. We termed this integration mode ''imbalance detection,'' because it responds maximally to extreme ratios (imbalances) of the two ligand concentrations. We note that the same 2-dimensional response profiles were observed using independently generated reporter cell lines, indicating that they do not reflect aspects of the chromatin configuration of a specific reporter integration site ( Figure S2C ). The integration functions were also independent of the ligand supplier ( Figure S2D ). Together, these results identify three distinct ways in which the BMP pathway can integrate ligand pairs.
Interestingly, these responses depend in distinct ways on the ligand composition, defined as the relative concentrations of the two ligands. To study this dependence, we plotted the response to varying relative ligand concentrations at high total ligand concentration ( Figures 2C-2E , dashed outline). These contours reveal that pathway activity is independent of ligand composition in the additive case ( Figure 2F ), monotonically dependent in the ratiometric case ( Figure 2G ), and non-monotonically dependent in the imbalance detection case, where pathway activity declines near a specific intermediate ligand ratio (Figure 2H ). Similar composition dependence can be observed at lower ligand concentrations. The only exception is imbalance detection, which at ligand concentrations <10 ng/mL becomes indistinguishable from the additive response ( Figure 2C ). These results indicate that the BMP pathway implements a diverse set of computations on multi-ligand inputs in NMuMG cells and can be strongly controlled by ligand composition, as well as absolute ligand concentration.
Response Profiles Emerge Rapidly and Are Stable We next asked at what level and over what timescales these response profiles emerge. First, to access an earlier and more direct readout of pathway activity, we measured SMAD1/5/8 phosphorylation at 20 min after stimulation with select ligand pairs, using immunostaining ( Figure 3A ) and western blots (Figures S2E and S2F) . Both measurements revealed qualitatively similar response profiles as the fluorescent reporter, indicating that computations emerge within 20 min and can be observed at the level of SMAD phosphorylation. We note that ERK1/2, a non-canonical output (Nohe et al., 2004) , did not respond to BMP stimulation in this cell context ( Figure S2G) .
Next, to better understand the dynamics of the BMP response, we used time-lapse imaging to track reporter expression over time in response to BMP4 and/or BMP10 (Figures 3B and S3A) . The imbalance detection response could be identified by 6 hr and persisted for more than 96 hr. However, the relative level of activation caused by the combination of BMP4 and BMP10, compared to the individual ligands, remained constant (Figure S3B) , indicating that the imbalance detection response profile is stable over extended periods.
Feedback Loops and Pathway Modulators
We next asked whether known feedback loops in the BMP pathway were necessary for the observed computations. The negative pathway regulator SMAD6 is a downstream target of BMP ( Figure S1B ) (Li et al., 2003; Afrakhte et al., 1998) . However, knockdown of SMAD6 did not qualitatively change the shape of the response profiles ( Figures S3C-S3E ). Another reported feedback involves upregulation of BMPR2 in response to BMP9 stimulation (Long et al., 2015) . Addition of 400 ng/ml BMP9 generated a 2-fold increase in BMPR2 expression (Figure S3F) . However, even this relatively modest effect appeared only at $12 hr, consistent with the timescales of transcriptional regulation and too late to explain the appearance of the computations at earlier time points. These results suggest that these feedback loops are not required for the computations observed here, although feedbacks may play other roles in enhancing the amplitude or dynamics of the pathway over longer timescales.
The BMP pathway utilizes many secreted and surface-bound modulators to shape the spatial distribution of available ligands. To test whether these factors play a role in ligand integration, we first determined which ones were expressed in the NMuMG cell line (Table S2) . Individually depleting each of these factors using siRNAs ( Figure 3C ) did not affect the type of response profile generated by BMP4 in combination with BMP9, BMP10, or GDF5 ( Figures 3D-3G ). In addition, BMPs could interact more generally with heparan sulfate proteoglycans (HSPGs). Enzymatically perturbing HSPGs with heparinase or inhibiting their biosynthesis with NaClO 3 showed minimal effects on the response of the pathway to BMP combinations ( Figures  S3G-S3J ). Together, these results suggest that while these modulators play key roles in other aspects of BMP signaling, they are not required for the observed multi-ligand computations. These results are, however, consistent with computations emerging directly from receptor-ligand interactions.
A Minimal Model of Promiscuous Receptor-Ligand Interactions
To understand how receptor-ligand interactions could generate the observed complex ligand integration modes, we constructed a simplified mathematical model that incorporates two key features of the BMP pathway: the bipartite structure of active (Heinecke et al., 2009; Massagué , 1998; Mueller and Nickel, 2012; Nickel et al., 2009; Vilar et al., 2006 phosphorylates SMAD proteins at a distinct rate, or activity, denoted ε ijk , to produce an overall output signal S at the steady state. The model considers the experimental regime of large extracellular volume, but similar conclusions occur at finite volume (STAR Methods). Here, we focus on the minimal case of 2 ligands, 2 A-type receptors, and 2 B-type receptors, whose behavior can be specified by 16 independent biochemical parameters and 4 receptor expression levels and which is sufficient to explain the present experimental observations. This simplified model omits several known features of the BMP pathway, such as variations in the sequence of binding reactions (Gilboa et al., 2000; Rosenzweig et al., 1995; Ventura et al., 1995) , the hexameric nature of actual signaling complexes, and the roles of other BMP regulatory factors. These features likely play important biological roles (e.g., controlling the amplitude and spatiotemporal dynamics of signaling) that should be considered in models of specific biological processes. However, incorporation of these additional features in the model does not change the types of input-output computations examined here (STAR Methods).
Archetypal Functions Define the Range of Response Profiles
To explore the range of integration modes produced by the model, we computed the input-output behavior of the system for 100,000 random parameter sets ( Figure S4A) . The model produced a repertoire of computational response profiles, which included additive, ratiometric, and imbalance detection. To more quantitatively characterize this repertoire, we defined two features that together capture key aspects of the shape of the response profiles ( Figures S4B-S4D ). First, we defined the relative ligand strength (RLS) to quantify the asymmetry in pathway
Additive
Ratiometric Imbalance Balance [D] ; ratiometric, [E] ; imbalance, [F] ; and balance, [G] activity generated by the ligands individually. The RLS is defined as the ratio of pathway activity produced by the weaker ligand to that produced by the stronger ligand. Second, we defined the ligand interference coefficient (LIC) to quantify the degree to which the two ligands positively or negatively synergize (STAR Methods). The LIC is defined by the deviation of pathway activity in mixed ligand environments beyond the range of the responses in single ligand environments. When plotted in this two-parameter phenotypic space, the simulated systems occupied a continuous region that loosely conformed to an inverted triangle ( Figures 4C and S4E ). Two vertices of the triangle strikingly resembled the ratiometric and imbalance detection functions observed experimentally (cf. Figures 4D-4F) . The third vertex, occurring for ligands with a RLS of 1 and a positive LIC, represented a new predicted behavior, which we termed ''balance detection,'' because it shows a maximal response when both ligands are present at a specific ratio. All other functions, including the additive interaction at RLS = 1, LIC = 0 ( Figure 4C , top middle), interpolated between these three archetypal functions ( Figure S4E ) (Hart et al., 2015; Tendler et al., 2015) . The archetypal functions identified here differ from standard Boolean logic, since they depend asymptotically on ligand ratios, rather than absolute concentrations (STAR Methods). These conclusions remain qualitatively similar if one considers a finite extracellular volume (STAR Methods; Figures S5A and S5B) . This analysis provides an intuitive way to understand the distribution of response profiles.
To better characterize the distribution of response profiles, we quantified the percentage of occurrences of each response type in regions around each of the archetypal responses ( Figures S5C  and S5D ). All archetypal behaviors occurred, regardless of whether parameters were chosen from a full range of values or restricted to a biologically relevant range (STAR Methods). However, parameters in the biological range showed enrichment for the additive, balance detection, and imbalance detection response profiles ( Figure S5E ). We further note that natural biological parameters could have been selected by evolution for functionality, including the ability to generate balance or imbalance detection. Together, these results show that this minimal model can generate the full range of observed response profiles for biologically reasonable parameter values.
Complex Response Profiles Emerge from the Interplay of Receptor-Ligand Affinities and Activities
We next asked how the archetypal ligand integration modes arise within the model. To do so, we analyzed the corresponding parameter regimes in more detail ( Figure S6 ). As expected, additive responses occur when the two ligands are approximately equivalent, forming signaling complexes with similar phosphorylation activities (ε i1k $ ε i2k ; Figures 5A and S6A ). By contrast, ratiometric behaviors occur when signaling complexes containing one ligand have higher activities than those containing the other ðε i1k ( ε i2k Þ, such that a weaker ligand competitively inhibits activation by the other, stronger ligand (Figures 5B and S6B) . Imbalance detection occurs when each receptor preferentially binds to a distinct ligand with which it forms a less active signaling complex ( Figures 5C and S6C ). When only one type of ligand is present, it can bind both receptors, forming signaling complexes with both higher and lower activity. When both ligands are present, the affinity preferences cause ligands and receptors to self-sort and predominantly form less active signaling complexes, reducing total pathway activity ( Figure 5E ). Finally, balance detection occurs through a similar mechanism, except that the relative affinities are reversed, favoring formation of more active signaling complexes when both ligands are present ( Figures 5D and S6D) .
A critical feature of the model is that the overall activity of the pathway depends not only on how much of each ligand is complexed with receptors but also on how that ligand is distributed across the range of distinct possible receptor complexes. In the model, simply changing the activities of the complexes can result in completely different response profiles ( Figures S4F and S4G) . As a result, addition of a second ligand can change not only the amount of the first ligand that is bound to receptors but also, more importantly, the distribution of that ligand across different potential signaling complexes with distinct activities. This could explain how two ligands can exhibit similar receptor preferences but still combine in qualitatively different ways with a third ligand.
Taken together, these results indicate that promiscuous receptor-ligand binding interactions are sufficient to produce a diverse repertoire of specific multi-ligand response profiles, including those observed experimentally. They reveal how the full functional repertoire can be understood as interpolating among three archetypal functions (ratiometric, imbalance detection, and the predicted balance detection function). Finally, they show how these functions arise through specific relations between the affinity parameters that control what receptor complexes will form and the activity parameters that control how the resulting signaling complexes contribute to the cellular response. Thus, as suggested experimentally, the full spectrum of observed computations requires only the ability of receptors and ligands to compete to form a variety of distinct signaling complexes, and differences in the relative activities of those complexes. Despite its simplicity, this system allows for remarkable computational diversity.
Receptor Expression Reprograms Ligand Response Profiles
Within an organism, different cell types generally express receptors at different levels. Changes in receptor expression could in principle alter BMP responses in similar, or different, ways compared to changes in ligand concentrations. To gain insight into the possible role of receptor expression in pathway computations, we varied receptor expression levels in the model while holding the biochemical parameter values (K
We repeated this analysis for different biochemical parameter sets. In these simulations, some biochemical parameter sets produced only a limited range of ligand integration modes ( Figure 6A , left), while others were more versatile, capable of generating a diverse range of computations as receptor expression levels were varied ( Figure 6A , right). The existence of such versatile parameter sets in the model suggests the hypothesis that different cell types, by expressing different receptor profiles, might compute different responses to the same ligands.
If the BMP pathway exhibits and utilizes such versatility, cell lines with different receptor expression profiles could show distinct response profiles for the same ligands. To test this hypothesis, we compared the response of NMuMG cells to E14 mouse embryonic stem (ES) cells, which express less BMPR2 and ACVR1 and more ACVR2B ( Figure 6B ). As a control, we also analyzed NIH 3T3 fibroblasts, which had similar receptor expression to NMuMG cells ( Figure 6B ). The ES cells indeed exhibited different response profiles than NMuMG for the same ligands . Most strikingly, BMP4 and BMP9 integrated in an additive fashion in NMuMG and NIH 3T3 but showed the balance detection archetype in ES cells (Figure 6C ). Other ligand pairs were also integrated similarly in NIH 3T3 and NMuMG but differently in ES cells (Figures 6D and 6E) . Together, these results show that cell lines differ qualitatively in their ligand integration modes and in a manner that correlates with their receptor expression profiles, as predicted by the model. Furthermore, these results also validate the model prediction of balance detection ( Figure 4G ).
Reprogramming Response Profiles by Direct Manipulation of Receptor Expression Levels
Finally, to test whether changes in receptor expression are sufficient to reprogram computations, we directly perturbed receptor Table S5 and STAR Methods for parameter values). For each set, multiple receptor expression profiles are plotted (individual dots). Dot color indicates the most similar archetype (cf. Figure 4C ). Figure S7 and Tables S3-S5. expression in NMuMG cells. Depletion of the most highly expressed type II receptor in this cell type, BMPR2, with small interfering RNA (siRNA) changed the BMP4-BMP9 response from additive to ratiometric (Figures 6F and S7C) . This indicates that BMP4 activates the pathway predominantly through BMPR2. By contrast, BMP9 can activate through other type II receptors, but BMP4 can effectively inhibit such BMPR2-independent BMP9 signaling.
As a second example, ectopically expressed BMPR1B, which is known to mediate GDF5 signaling (Nishitoh et al., 1996) , enabled GDF5 to activate, rather than inhibit, the pathway, and thereby reprogrammed the ratiometric BMP4-GDF5 interaction to an additive one (Figures 6G and S7C) . Furthermore, combining ectopic BMPR1B to enable GDF5 signaling with depletion of BMPR2 to reduce BMP4-dependent signaling inverted the ratiometric response ( Figures 6G and S7C ).
Third, we asked whether we could reprogram imbalance detection between BMP4 and BMP10 ( Figure 2E ). In the model, imbalance detection results from ligand competition for receptors. To alleviate this competition, we ectopically expressed the ALK1 receptor, which is known to mediate BMP9 and BMP10 signaling (David et al., 2007) . This perturbation indeed removed competition, generating the predicted additive response (Figures 6H and S7C) .
Taken together, these results show that receptor expression levels directly control computations and demonstrate that this effect enables rational manipulation of ligand integration modes using insights from the model ( Figure S7B ).
DISCUSSION
Our results show that promiscuous BMP receptor-ligand interactions enable cells to perceive information encoded in combinations of ligands ( Figure 7 ). They do so through a specific set of computations over the multi-dimensional space of ligand concentrations, with the computations performed on a given set of ligands depending on the repertoire of receptors the cell expresses. These computations interpolate between archetypes loosely analogous to addition (additive, Figure 4D ), subtraction (imbalance detection, Figure 4F ), multiplication (balance detection, Figure 4G ), and division (ratiometric, Figure 4E ). This indicates that cells do not, in general, perceive ligand abundance but rather perceive specific functions of ligand combinations.
This system provides several key capabilities for cells. First, it is sensitive to both absolute concentrations of individual ligands and their relative concentrations. Encoding signals in relative ligand concentrations can increase robustness to variations in ligand accessibility, cell surface area, and other properties that affect all ligands in a correlated way. Second, computation is integrated with sensing. The system performs computations on ligand concentrations directly through competitive binding interactions, at steady state, without requiring regulatory cascades or transcriptional feedback loops. The observed computations arise because affinities among components need not correlate with the activities of the resulting signaling complexes. This allows ligands to compete for receptors to form a variety of distinct signaling complexes with distinct efficiencies. Third, and most intriguingly, this system possesses computational plasticity. By controlling the abundance of different receptor variants, a cell can control which computations it performs, and thus what features of the ligand environment it responds to. These capabilities could enable non-intuitive operative modes. For example, the use of ligand combinations may offer the ability to selectively activate a given cell type, since different cell types may respond to specific ligand combinations. Temporal changes in the concentration of a single ligand could elicit different, or opposite, changes in signal perception in distinct cell types.
These results should improve our ability to understand and manipulate natural BMP-dependent processes. For example, efficient primordial germ cell differentiation was shown to require a combination of both BMP4 and BMP8B homodimers, provoking the question of whether these ligands are integrated through balance detection (Ying et al., 2001) . Conversely, BMP2 and BMP7 show opposing effects on ureter branching in developing kidneys (Piscione et al., 1997) , suggesting they may operate in a ratiometric mode, and similar interactions were recently reported for BMP2 and GDF5 in multiple contexts (Klammert et al., 2015; Liu et al., 2016) . The framework described here can be used to analyze these and other specific biological processes that utilize multiple BMPs (Aç il et al., 2014; Bandyopadhyay et al., 2006; Chen et al., 2013) . In the context of disease, many therapeutic strategies have focused on using a single ligand to treat conditions such as bone injuries and abnormalities, arthritis, diabetes, vascular conditions, obesity, and cancer (Kim and Choe, 2011; Wang et al., Ligand combinations represent inputs to the pathway, which processes them through receptor-ligand interactions to control the expression level of downstream target genes. In this scheme, a given receptor configuration can perform different computations on different ligand combinations (e.g., additive and imbalance, top), whereas cells expressing different receptor profiles can perform distinct computations on the same combination of ligands (e.g., ratiometric and additive, bottom).
2003). Similarly, directed differentiation approaches in regenerative medicine often rely on a single BMP ligand. However, ligand combinations may provide more potent, and specific, control in these contexts.
Further work on higher dimensional combinations of ligands, as well as investigation of the effects of diffusible inhibitors such as Noggin and Chordin, will help to provide an understanding of systems like kidney development that depend on many different ligands, receptors, and modulators expressed in spatially and temporally overlapping patterns (Simic and Vukicevic, 2005) . Similarly, quantitative analysis of receptor expression states will help elucidate the specific combination of ligands that each cell type senses. Experimental measurements of the effective parameter values for each specific molecular component in the BMP pathway could enable a more direct, quantitative, and predictive modeling framework. At a finer level, within a single cell type or state, fluctuations, or ''noise,'' in receptor expression could affect how cells perceive ligand combinations. However, within the model, typical levels of receptor expression noise show only mild effects (Figures S7D-S7H ; STAR Methods).
Finally, further analysis could reveal additional computations beyond those described above. Extending the model to include the TGF-b ligands could be used to understand newly discovered ligand-level competition between the two branches of this signaling pathway (Hatsell et al., 2015; Lowery et al., 2015; Olsen et al., 2015) and incorporate them into a single framework. More generally, Wnt, FGF, JAK-STAT, Eph-Ephrin, and other signaling pathways also exhibit promiscuous interactions between multiple ligand, receptor, and co-receptor variants and may function according to similar principles (Jørgensen et al., 2009; Murray, 2007; Wodarz and Nusse, 1998) . Future elucidation of the principles of programmable computation through promiscuous receptor-ligand interactions could be used to engineer precise multicellular behaviors for synthetic biology and tissue engineering applications.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Tissue culture and cell lines NMuMG (NAMRU Mouse Mammary Gland cells, female) and NIH 3T3 (mouse fibroblast, male) cells were acquired from ATCC (CRL-1636 and CRL-1658, respectively). E14 cells (mouse embryonic stem cells, E14Tg2a.4, male) were obtained from Bill Skarnes and Peri Tate. All cells were cultured in a humidity controlled chamber at 37 C with 5% CO 2 . NMuMG cells were cultured in DMEM supplemented with 10% FBS (Clonetech #631367), 1mM sodium pyruvate, 1unit/ml penicillin, 1mg/ml streptomycin, 2mM L-glutamine and 1X MEM non-essential amino acids. NIH 3T3 cells were cultured in DMEM supplemented with 10% CCS (Hyclone #SH30087), 1mM sodium pyruvate, 1unit/ml penicillin, 1mg/ml streptomycin and 2mM L-glutamine. ES cells were plated on tissue culture plates pre-coated with 0.1% gelatin and cultured in standard pluripotency-maintaining conditions (Smith, 2001) using DMEM supplemented with 15% FBS (ES qualified, GIBCO #16141), 1mM sodium pyruvate, 1unit/ml penicillin, 1mg/ml streptomycin, 2mM L-glutamine, 1X MEM non-essential amino acids, 55mM b-mercaptoethanol, and 1000Units/ml leukemia inhibitory factor (LIF).
Sensor cell lines construction
Construction of the reporter cell lines was carried out via random integration of a plasmid harboring the BMP response element (BRE) (Korchynskyi and ten Dijke, 2002) in the enhancer region of a minimal CMV driving the expression of an H2B-Citrine protein fusion. ES cells were transfected using the FugeneHD reagent. NMuMG and 3T3 cells were transfected using Lipofectamine LTX. After transfection, cells were selected with 100mg/ml hygromycin. All experiments were performed with clonal populations, generated via colony picking (ES) or limiting dilutions (NMuMG, NIH 3T3). To ensure results were not dependent on the specific reporter integration site, an independent BRE-reporter cell line was generated using PiggyBac integration (SBI) ( Figure S2C ). Table S3 ) This paper See Table S3 siRNA targeting BMP modulators (see Table S3 ) This paper See Table S3 qPCR primers and probes (see Table S4 ) This paper N/A qPCR primers (see Table S4 
METHOD DETAILS
BMP response and flow cytometry Sensor cell lines were plated at 40% confluency in 96 well plates and cultured under standard conditions (above) for 12 hr. Media was then replaced and ligand(s) were added at specified concentrations. 24 hr after ligand addition, cells were prepared for flow cytometry in the following way: Cells were washed with PBS and lifted from the plate using either 0.05 mL Accutase (ES cells) or trypsin (NMuMG and 3T3 cells) for 5 min at 37 C. Protease activity was quenched by re-suspending the cells in HBSS with 2.5mg/ml Bovine Serum Albumin (BSA). Cells were then filtered with a 40mm mesh and analyzed by flow cytometry (MACSQuant VYB, Miltenyi). All recombinant BMP ligands were acquired from R&D Systems (Table S1) , with the exception of Figure S2D where BMP4, BMP10 and GDF5 were acquired from Peprotech.
Ligand integration survey
In order to identify non-additive ligand integration modes, cells were exposed to a matrix of ligands at predetermined concentrations. We selected concentrations that were sufficient to induce responses in cells already known to respond to those ligands, but not so high as to induce potential non-specific responses. For this reason, we based ligand concentrations on supplier data, and selected a concentration at the high end of the input dynamic range for a cell based system susceptible to each ligand (see Table S1 ). All BMP ligands used in the survey were acquired from R&D Systems (see Table S1 for more information).
SDS-PAGE and immunoblotting
Phospho-SMAD1/5/8 For assessment of phospho-SMAD1/5/8, cells were plated at 40% confluency under standard conditions in 24 well plates. To reduce phospho-SMAD1/5/8 background activity, cells were transferred to reduced serum media containing 1.0% FBS for 12 hr. This media was then exchanged for DMEM and cells were incubated at 37 C for another 6 hr. DMEM was then replaced and ligands were added in DMEM at the specified concentrations and incubated at 37 C for 20 min. Cells were then treated with 50ml lysis buffer (Cell Signaling 9803) with the following additions: 0.1M DTT, 50mM NaF, 1mM PMSF and additional protease inhibitors (Thermo 87785). Samples were immediately stored at À80 C until processed for SDS-PAGE. SDS-PAGE was conducted using NuPAGE Bis-Tris Mini Gels 4%-12% (Thermo). Approximately 10-20mg of total protein, denatured by heat, was loaded per well. Samples were run at 50mA for approximately 60 min. Protein was transferred from gels to nitrocellulose using the iBlot apparatus and iBlot reagents (Thermo) applying program 2 for 8 min. Membranes were trimmed and blocked with 5% milk in Tris buffered saline with 0.1% Tween 20 (TBST) for at least 60 min at room temperature. Blocking buffer was removed and membranes were briefly washed with TBST. Antibodies against phospho-SMAD1/5/8 (13820 Cell Signaling), phospho-p44/42 MAPK (4370 Cell Signaling), SMAD1 (6944 Cell Signaling), GAPDH (2118 Cell Signaling) were than applied at a dilution of 1:1000, 1:2000 for GAPDH, in 1.0% BSA TBST and incubated at 4 C for 12 to 16 hr. After incubation with primary antibody, immunoblots were washed with TBST three times for 5 min at room temperature and a secondary antibody conjugated with horseradish peroxidase (7074 Cell Signaling) was applied to the blots at 1:1000 in 1.0% BSA TBST for 60 min at room temperature. After incubation with the secondary antibody, the immunoblots were washed with TBST three times for 5 min and developed using a luminol based substrate (7003 Cell Signaling). The immunoblots were imaged using a BioRad ChemiDoc MP imaging system using exposure times that produced signal below saturation. Densitometry was performed using ImageJ (https://imagej.nih.gov). BMPR2 For assessment of BMPR2 protein expression after addition of select BMP ligands, cells were plated at 40% confluency under standard conditions in 24 well plates. Media was replaced, with addition of BMP9 (400ng/ml), and cells were then incubated at 37 C for the specified times. Cells were then treated with 50ml lysis buffer (see above). Samples were immediately stored at À80 C until processed for SDS-PAGE. After electrophoresis, gels were incubated with 20% ethanol in TBS for 5 min. Transfer of protein to nitrocellulose was performed with the iBlot apparatus using program 3 for 8 min. Antibodies against BMPR2 (6979 Cell Signaling) and GAPDH (2118 Cell Signaling) were then applied at 1:1000 and 1:2000, respectively, in 1.0% BSA TBST and incubated at 4 C for 12 to 16 hr. Immunoblots were processed, developed, and analyzed as described above.
BMP response with heparinase I/III Cells were plated at 40% confluency in 96 well plates and cultured under standard conditions for 12 hr. Media was exchanged with media containing 2 units of Heparinase I/III (H3917 SIGMA) and cells were incubated at 37 C for 3 hr. Media was then replaced with media containing ligands at the specified concentrations. The cells were then incubated with ligands at 37 C for 20 min. After incubation for 20 min the cells were processed for phospho-SMAD1/5/8 staining and flow cytometry as described above.
BMP response with NaClO 3
Sensor cells were plated at 40% confluency under standard conditions including 20 mM NaClO 3 (Sigma) and passaged 36 hr later at 40% confluency in 96 well plates under the same conditions and cultured for another 12 hr. Media was then replaced and ligands were added at the specified concentrations. The cells were then incubated with ligands at 37 C for 24 hr and were processed for flow cytometry as previously described.
Receptor overexpression
Overexpression plasmids were constructed for each of the BMP receptors (BMPR1A, BMPR1B, BMPR2, ACVR1, ACVR2A, ACVR2B and ALK1) using the Gibson cloning method (Gibson et al., 2009 ). Bmpr1b and Alk1 cDNA was purchased from Dharmacon (MMM1013-202858407 and MMM1013-202763719). All other receptor cDNAs were generated by RT-PCR from total RNA extracted from NMuMG cells. The receptor cDNA was concatenated with mTurquoise with an intervening T2A cleavage site (Szymczak and Vignali, 2005) , and was expressed under the control of a constitutive PGK promoter integrated in the Pb510b plasmid backbone to enable PiggyBac integration (Ding et al., 2005; Wu et al., 2006) . Stable integrations were then generated using the PiggyBac method. Cells were co-transfected with these overexpression plasmids and PB200A to express transposase, and selected with Geneticin. Experiments were performed with polyclonal populations resulting from PiggyBac integrations.
siRNA induced knock-down Cells were plated at 40% confluency with 30mM total siRNA (ThermoFisher silencer select #4390771) and 3ml RNAiMAX (Life technologies). For every gene, a pool of two distinct siRNAs was used, listed in Table S3 . Cells were passaged after 24 hr and were used for the relevant experiments.
Quantitative PCR Total RNA was harvested from cell lysate using the RNeasy mini kit (QIAGEN) and cDNA was generated from 1mg of RNA using the iScript cDNA synthesis kit (BioRad) following the manufacturer's instructions. Primers and probes for specific genes (Table S4) were purchased from IDT. Reactions were performed using 1:40 dilution of the cDNA synthesis product with either IQ SYBR Green Supermix or SsoAdvanced Universal probes Supermix (BioRad). Cycling was carried out on a BioRad CFX96 thermocycler using an initial denaturing incubation of 95 for 3 min followed by 39 cycles of (95 C for 15 s, followed by 60 C for 30 s). Each condition was assessed with two biological repeats and each reaction was run at least in triplicate.
Antibody detection for phospho-SMAD1/5/8 Cells exposed to specified concentrations of BMP4 for 24 hr were harvested from single wells of a 24 well plate using either 0.05mL Accutase (ES cells) or trypsin (NMuMG and 3T3 cells). Protease activity was quenched by re-suspending the cells in 0.45mL HBSS with 1.0% Bovine Serum Albumin (BSA). The cells were then pelleted, washed with 0.5mL PBS, and fixed by re-suspension in 0.5mL of 4.0% formaldehyde for 5 min at room temperature. Following fixation, the cells were washed in 0.5mL PBS and re-suspended in 0.5mL PBS with 1.0% Triton X-100 for permeabilization. The cells were then washed with 0.5mL PBS and re-suspended in blocking solution (PBS with 1.0% BSA and 0.1% Tween 20). Blocking was carried out for 30 min at room temperature. The cells were then pelleted and re-suspended in binding solution (PBS with 1.0% BSA) containing a 1:100 dilution of a primary antibody against the phosphorylated form of SMAD1/5/8 complex (Cell Signaling Technologies Cat# 13820). The staining proceeded for 12 À16 hr at 4 C with constant rocking. Afterward, cells were washed with 0.5mL PBS and re-suspended in binding solution containing a 1:500 dilution of a secondary antibody labeled with Alexa 594 (#A21207, ThermoFisher). Secondary detection proceeded for 60 min at room temperature with constant rocking. Finally, cells were then pelleted, washed with 0.5mL PBS filtered with a 40mm mesh and analyzed by flow cytometry.
Time-lapse imaging
Fluorescent reporter cells were first mixed with an excess of non-fluorescent parental cells at a 1:9 ratio to simplify image segmentation and data extraction. Cells were then plated at 1.6$10 4 cells/well in a 96 well plate equivalent roughly to 15%-20% confluency. Cells were grown for 12 hr prior to ligand addition. Each position was imaged every hour starting from the addition of ligands until cells became confluent after about 60 hr. Images were then analyzed for the number of fluorescent cells and fluorescent signal level.
Mathematical model for promiscuous interactions
Many signaling pathways comprise multiple ligand and receptor variants that interact promiscuously with one another, with varying affinities, to form many distinct signaling complexes. BMP provides a canonical example of this architecture. However, other pathways, including TGF-b (SMAD2/3) signaling, FGF, Wnt, and JAK/STAT, also exhibit similar features. Here we develop a general mathematical model that captures essential aspects of receptor-ligand promiscuity in signaling pathways, and analyze it to understand the functional capabilities this architectural feature provides for cellular signal processing. This model focuses on several features of the natural BMP pathway: promiscuous ligand-receptor interactions, heterodimeric receptors (a simplified version of the natural Type I-Type II receptor tetramers), and variation in the activities of different signaling complexes. To focus on the signal-processing capabilities at the level of receptor-ligand interactions, we neglect other known features of the pathway including preliminary enzymatic processing of ligands, non-canonical signaling, downstream feedback loops (e.g., through SMAD6/7), and crosstalk with other signaling pathways. We specifically point out that while this model focuses on mixtures of ligand species, each ligand type is composed of two subunits. Thus the model can be used equally well for mixtures of homodimers, heterodimers, or combinations thereof. Finally, we note that while the model applies most directly to the BMP pathway, variants of it could also describe other systems that similarly form multi-part signaling complexes, including receptor aggregates, such as those listed above.
We 
Next, we can write the dynamical equations that describe these reactions:
Here, L j denotes the concentration of the ligand in a volume V, and A i ; B k ; D ij and T ijk are the absolute number of receptors and complexes on the cell surface. We assume here that production and consumption are in a steady state enabling us to neglect the consumption of receptors and ligands by endocytosis. Subunits combine to form various complexes; however, the principle of conservation of mass requires that the total number of each type of molecule remain constant: i are the total receptor levels. Finally, each complex T ijk induces phosphorylation of the intracellular signal, S, at some rate e ijk so that the rate of change of the total signal is given by
We consider the case where the volume for the ligand is large such that there are significantly more ligand molecules than receptors, which can be expressed by V/N. This reflects our experimental conditions where the ligands are dissolved within a large excess of cell culture media. With this assumption Equations 3 and 8 decouple and become
Additionally, since binding and unbinding occur on fast timescales (minutes (Heinecke et al., 2009 )) compared to the timescales of reporter expression, we focused on the behavior of this system at steady state. In this regime, all time derivatives in Equations 4-7 vanish and the system can be solved to give
)
where we define K 
with ε ijk he ijk =g. Therefore, the final system of equations describing our model is given as follows
This system comprises a set of
Solving the steady-state equations In order to find the total signal, S, we first need to solve the system of equations to find T ijk . Plugging Equation 18 into Equation 16 we find
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This can be used to solve for D ij
which we can plug into Equation 19 to get a coupled set of N = n A ,n L ,n B quadratic equations for T ijk
Solving Equation 23, we can then obtain the signal S using Equation 20.
The error function and least square minimization In order to solve Equation 23, we minimize an error function, defined as follows:
Here, E is a function of the complete set of T ijk 's. It is always positive, being a sum of squares, and vanishes if and only if T ijk is a solution to Equation 23, which can now be written as
This equation is now in a form that can be solved numerically for any given set of parameters via standard optimization methods such as MATLAB's fmincon and lsqnonlin functions.
Dimensional reduction
The system of equations describing our model can be simplified by dimensional reduction, in which we redefine the variables to reduce the number of parameters and make the remaining parameters dimensionless. First, we change the units of signal strength using a scaling factor, a.
S/a,S
By choosing a value of a = ð P i;j;k ε ijk Þ À1 , we can obtain units such that the phosphorylation rate constants for all complexes sum to 1:
Similarly, changing the receptor units by rescaling with a factor b gives rise to the following transformation: Finally, we can also independently choose new units for each individual ligand species:
We can make these dimensionless by choosing
Using these re-scaled variables and parameters, we can explore the complete parameter space by examining only parameter values satisfying Equations 27, 29, and 31. These constraints reduce the number of independent parameters, N p , by 2 + n L .
The (2,2,2) k . In order to study all possible behaviors, random sets of parameters were chosen. We chose random biochemical parameters distributed uniformly over the bounded domains defined by Equations 27, 29, and 31, while the receptor parameters were chosen from a log-uniform distribution in the range ½10 À3 ; 10 3 . Simulations were performed for 100,000 random parameter sets, and an entire 2D input-output function, across 15 3 15 log-uniform ligand concentrations, was numerically computed for each set. Results are plotted in Figure S4A .
Phenotypical parameters
A useful representation of the modeling results can be achieved by extracting parameters that measure phenotypic characteristics of the computation performed for each of the parameter sets. In this study we focused on two such parameters, the relative ligand strength (RLS) and the ligand interaction coefficient (LIC), as diagrammed in Figure S4B -D. More specifically, we define RLS as follows:
where S strong and S weak are the activation strengths of the pathway when induced by the stronger or weaker ligand individually, at saturating levels. In the case where one ligand is a potent activator while the second ligand is weak this index drops to 0. However, when both ligands individually activate the pathway to a similar extent, this index approaches 1. LIC measures the effective interaction between the ligands at high ligand concentration ðL j [ 1Þ. We define the satmax and satmin functions to be the maximal or minimal response, respectively, over varying ligand ratios, at saturating total ligand concentrations ( Figure S4B-S4D ). Using these functions, the ligand interference index can be defined as
For non-interacting ligands, we expect that mixed levels of ligands produce responses that lie within the range defined by the effects of the individual ligands, in which case the coefficient vanishes. However, if a combination of ligands gives rise to a stronger response than that of the stronger ligand individually, the first term generates a positive value for this index. On the other hand, if the response to a combination of ligands is smaller than the weaker ligand, the second term dominates, and the index becomes negative. The range for this index is therefore ½À1; 1.
The four archetypes and the structure of parameter space Plotting the values of LIC and RLS for each simulation, we find that the response profiles form a continuous distribution that interpolates between 4 archetypal computations ( Figures 4C and S4E ). These archetypal computations generally map to different regions in parameter space. Here we describe in more detail the parameter regimes that give rise to each of these archetypes. Additive ( Figure S6A ) The additive integration can be thought of as the ''default'' computation. It occurs when both ligands have equivalent receptor affin-
) and they produce equivalently active complexes ðε i1k $ ε i2k Þ. In such a regime, similarly active complexes form regardless of whether one ligand, the other, or both are present, and thus, the response does not depend on the composition of the ligands but only on the total ligand concentration in the environment. This simple computation can occur even when there is only a single receptor variant ðn A = n B = 1Þ. Ratiometric ( Figure S6B ) Ratiometric computation occurs when the ligands produce signaling complexes with significantly different activity levels ðε i1k [ ε i2k Þ. When L 1 is present, high activity complexes ðT i1k Þ form and the pathway is strongly activated. In contrast, when only L 2 is present, only low activity complexes ðT i2k Þ form and the pathway is weakly activated. In a mixed environment, L 2 will compete with L 1 for receptor binding, competitively inhibiting formation of the more active complexes, and thus reducing pathway activation below its maximal level in a ratiometric manner. Note that this computation can also occur with only a single receptor variant ðn A = n B = 1Þ, and that similar ratiometric sensing behaviors have been observed in other systems (Atkinson, 1968; Berg et al., 2009; Escalante-Chong et al., 2015; Madl and Herman, 1979) . Imbalance detection ( Figure S6C ) Imbalance detection can be thought of as a combination of two opposing ratiometric computations, and thus requires the existence of at least two receptor variants, A 1 with ε 11k [ ε 12k and A 2 with ε 21k ( ε 22k . Moreover, receptor-ligand affinities should be such that each receptor preferentially binds to the ligand with which it forms the weaker complex, i.e., K
. In this regime, when only a single ligand is present, it can bind both type A receptors, leading to formation of both the more active and less active signaling complexes. However, when both ligands are present simultaneously, they compete for type A receptor, producing primarily the high affinity signaling complexes, which, in this regime, are precisely those with weaker activity. Thus, in this case, the ligands effectively reduce each other's ability to activate the pathway. Balance detection ( Figure S6D ) Balance detection occurs in a similar way as the imbalance modes, except that the affinities favor the formation of the more active signaling complexes. We still have ε 11k [ ε 12k and ε 21k ( ε 22k , as with imbalance detection. However, for this computation,
, such that higher affinity receptor-ligand pairs now correspond to the higher activity complexes. Consequently, as before, a mixture of ligands will produce mostly the higher affinity complexes (T 11k and T 22k ), but now these complexes have higher, rather than lower, activity.
Furthermore, the balance detection effect can be enhanced by further reducing the activating effects of individual ligands. Consider the case where only L 1 is present. Lack of competition enables binding of L 1 to both type A receptors giving rise to D 11 and D 21 . If affinities of these dimeric complexes for B-type receptors obey K T 11k < K T 21k then there will be more trimeric complexes of the form T 21k than T 11k . Assuming the high activity complexes are similarly active to each other, ε 11k $ ε 22k , then ε 21k ( ε 11k , and therefore, the enrichment for T 21k will tend to decrease the total signal, further enhancing the balance detection effect.
Computations depend only on ligand ratios at high ligand concentrations A striking feature of the computations performed by the ligand-receptor interactions ( Figure S4A ) is the appearance of diagonal contours in the log-log ligand space. These reflect a general dependence of output on ratios of the two ligands. In fact, this behavior is more general, occurring for any number of ligands and receptors, and can be understood from the model. This can be seen by examining Equation 23, where the ligand dependence is entirely through the factor
Here, on the right-hand side, we have introduced R jj 0 hL j 0 =L j to represent the ratios between each pair of ligands. When ligand concentrations are large, L j [ 1, the 1=L j vanishes and the solution depends only on ratios between ligands and not on their absolute levels.
Archetypal computations differ from Boolean logic gates
It is also interesting to note that the previous observation suggests a significant distinction between the observed computations, e.g., the archetypes in Figure 4 , and Boolean logic functions. Superficially, the additive, imbalance and balance computations resemble Boolean OR, XOR, and AND gates, respectively. However, a key feature of Boolean logic is the existence of threshold levels that can be used to binarize inputs. For example, to behave like a Boolean AND gate, one would expect that when both inputs are each above some threshold, the output should always be ''on.'' By contrast, in the computations analyzed here, no such thresholds exist. For example, in an imbalance detection mode, consider two ligand concentrations L 1 and L 2 that individually activate, but produce a weaker response together, i.e., appear to represent two ''high'' input levels that together produce a ''low'' output. Because output depends only on ligand ratios, for any value of L 1 chosen here, we can find a concentration of the second ligand, L 0 2 > L 2 that will decrease the ligand ratio enough to generate a ''high'' output. Similar considerations apply for the balance detection computation.
Biological parameter range
In our analysis of model response profiles, we selected random values for dimensionless parameters, distributed across the entire theoretical possible range. This allowed us to understand the full repertoire of theoretically possible responses. We then restricted the analysis to biologically plausible values for each of the parameters to constrain the analysis to biologically relevant regimes. For receptor expression, based on previous measurements of the number of TGF-b receptors in different cell lines (Wakefield et al., 1987) , we chose the total receptor counts A 0 i and B 0 k in a log-uniform distribution in the range ½0; 9,10 4 . For the ligand levels L 0 i , we considered the range of experimentally utilized ligand concentrations: ½10 À1 ; 10 3 ng/ml. To make it comparable with the units for the receptor we converted this range to units of molecules, assuming a typical molecular weight for BMP ligands of about 30 kDa. This produced a concentration range of ½10 À12 ; 10 À8 M. Multiplying by a typical eukaryotic cell volume of 2,10 3 mm 3 , we estimate ligand numbers per cell volume in the range of ½1; 10 4 molecules. When receptors and ligands are measured in number of molecules, the affinity parameters K ij and K ijk have units of molecule -1 (i.e., per molecule). Using estimates in the literature based on surface plasmon resonance measurements (Aykul and Martinez-Hackert, 2016), as well as theoretical models (Nicklas and Saiz, 2013), we conservatively selected affinities from a log-uniform distribution over the range ½10 À3 ; 10 À1 . Finally, the efficiency parameters ε ijk have arbitrary units that define the scale of the response and thus were chosen uniformly in the range [0, 1] without loss of generality.
Using these ranges, we selected 100,000 random parameter sets and performed simulations to compute the input-output functions for each parameter set across a 9 3 9 matrix of ligand concentrations. The results show that a full range of response profiles could occur (Figures S5C and S5D ). Further quantification of the relative frequencies of each response profile revealed a decreased frequency of ratiometric responses and increased frequencies of other functions, compared with the unrestricted parameter screen ( Figure S5E ).
Versatility search
A key aspect of the model is that it permits the cell to change the computation performed on a pair of ligands by modulating receptor expression. In order to study the effect of receptor expression levels on the computation performed, we selected 1000 random biochemical parameter sets. For each, we simulated the model with varying expression levels of each of the 4 receptor subunits ðA 1 ; A 2 ; B 1 ; B 2 Þ systematically chosen from a log-uniform distribution over the range ½10 À3 ; 10 3 . The distribution of LIC and RLS values over the receptor expression levels was then calculated. These distributions were plotted for two specific biochemical parameter sets (one versatile and one non-versatile) in Figure 6A . The biochemical parameters are provided in Table S5 .
Robustness to perturbations in receptor expression
Both theoretical and experimental analysis revealed that changes in receptor expression levels can reprogram the computation performed by cells. This observation provokes the question of how the computation could vary in response to fluctuations, or 'noise', in receptor expression levels (Elowitz et al., 2002) .
We consider two types of fluctuations in receptor levels. First, there might be overall, correlated fluctuations across all receptors. Such extrinsic noise might reflect global changes in expression machinery, as well as fluctuations due to cell growth and division. Second, each receptor could vary stochastically in its expression, leading to independent fluctuations, or intrinsic noise. More quantitatively, we defined the receptor noise v as the coefficient of variation of receptor level. In addition, we defined a E and a I as the relative proportions of extrinsic and intrinsic noise, with a E + a I = 1.
To simulate the extrinsic noise, we generated a scale factor, s, drawn from a gamma distribution with shape parameter a E =v 2 , and scale parameter v 2 (giving a mean of a E and variance a E v 2 ). Similarly, intrinsic noise was simulated by a choosing a receptor dependent scale factor s i , drawn from a gamma distribution with shape parameter a I =v 2 and scale parameter v 2 (mean a I and variance a I v 2 ). To add noise to the receptor expression levels we multiplied the mean receptor level, R 0 i , by a combined scale factor ðs + s i Þ. This combined scale factor has mean 1 and variance v 2 , giving rise to the desired coefficient of variation. We then set out to analyze cellular sensitivity to receptor perturbation across the spectrum of ligand computations. We randomly chose 100 parameter sets from each of 5 regions in the phenotypic space defined by RLS and LIC. These regions were chosen to represent the additive (À0.05 < LIC < 0.05, RLS > 0.8), ratiometric (À0.05 < LIC < 0.05, RLS < 0.2), imbalance (LIC < À0.1, RLS > 0.8), and balance (LIC > 0.1, RLS > 0.8) archetypes, as well as an intermediate region (À0.05 < LIC < 0.05, 0.4 < RLS < 0.6) that represented part of the spectrum of input-output functions but was not specifically associated with a single archetype. For each parameter set, we performed perturbations using 3 types of noise: purely extrinsic noise ða E = 1; a I = 0Þ, purely intrinsic noise ða E = 0; a I = 1Þ, or a combination of extrinsic and intrinsic noise ða E = 0:5; a I = 0:5Þ. To enable comparison of the effects of each type of perturbation, we used a fixed coefficient of variation, v = 0:25.
Representative examples for each region ( Figures S7D-S7F) show the spread of the resulting functions in phenotypic space. We find that extrinsic noise generates comparatively small quantitative changes in response profiles relative to intrinsic noise, with the combination of extrinsic and intrinsic noise showing an intermediate effect. To systematically characterize the variation in phenotypic space, we analyzed the distribution of the standard deviations of the change in RLS and LIC across all perturbations for each parameter set ( Figures S7G and S7H ). While these differences are generally insufficient to change the class of input-output function observed, we find that intrinsic noise produces greater variability in the phenotypic parameters. These results suggest that the observed input-output functions in the model of the BMP signaling pathway depend primarily on relative ratios of receptor levels rather than absolute numbers.
Finite volume of extracellular space
In the experimental context, cells were exposed to a large volume of media such that the total amount of ligand was much greater than the number of receptors. Using this high volume assumption results in constant ligand levels, even as they bind receptors to form active complexes (Equation 12 ). However, this regime might not necessarily be applicable to all in vivo contexts where the exact ratio of ligands to receptors could vary, and titration of ligands by receptors can affect their concentration. Therefore, it is noteworthy to consider also the case of a finite volume. Under these conditions, the steady-state equations, (Equations 16-20) become
Plugging Equations 38 and 39 in 35-37 we get:
which can be numerically solved as before. We see that the distribution of behaviors remains similar with all four behaviors arising even in the finite volume regime ( Figure S5A ). Additionally, one can also ask how the finite volume assumption impacts the computations. To test this, we considered both models for every set of parameters and compared the resulting behavior. While the two models give rise to qualitatively similar responses to increasing ligand levels, they differ specifically at intermediate ligand levels (Figure S5B) , where the finite model produces a sharper dependence on ligand concentration, or, equivalently, a reduced input dynamic range.
Signaling modifiers
In addition to receptors and ligands, other secreted and cell bound proteins could in principle reshape the activity of pathway elements. In the BMP pathway many such modifiers are known, including secreted ligand-binding molecules (e.g., Twsg, Chordin, Noggin) and pseudo-receptors (e.g., BAMBI). While these factors were not explicitly modeled, they can be incorporated within the same formalism. Ligand binding molecules can generally form complexes with ligands, just as the receptors do. Therefore, mathematically they are equivalent to type A receptors, with affinities that can be specified in the corresponding elements of K D ij . Since these modifiers are secreted, the resulting complexes will not form complexes with type B receptors, and will not produce active signaling complexes. In the model, this can be represented by 0 values for the corresponding elements of both K We therefore see that the modeling framework can naturally extend to include many biologically relevant components of the BMP pathway. While these elements do not play critical roles in the in vitro setting explored in this manuscript, they could play more important roles in vivo.
Nonlinear signal accumulation
Another assumption in the model is that the receptors all contribute linearly to the overall total phosphorylation rate (Equation 11 ). This assumption holds when the dephosphorylation rate is large compared with the phosphorylation rate, such that there is a large pool of dephosphorylated SMAD protein. A similar assumption was utilized in various models of the BMP and TGF-b pathway such as in (Vilar et al., 2006) , and is motivated by experimental results of the TGF-b dependent phosphorylation and dephosphorylation rates (Inman et al., 2002) . Since distinct cell types can differ in their kinase level, among others, it is biologically interesting to consider what happens in a regime where this assumption does not hold. The full equation describing the phosphorylated SMAD signal ðS p Þ should be written as
where S u is the amount of unphosphorylated SMAD and g is the dephosphorylation rate. Using S tot = S u + S p , we get
Solving for the steady-state solution one finds
where we define ε ijk = e ijk =g as before. From this we see that for slow total phosphorylation rates,
( 1, we recover the linear behavior (Equation 20 ). However, when the phosphorylation rates become faster, compared to the characteristic dephosphorylation rate, the response reaches saturation. It is important to note that overall the signal is still determined by a monotonically increasing function of the weighted sum of all trimeric complexes. Therefore, while the quantitative nature of the computations can depend on the exact ratio between phosphorylation and dephosphorylation rates, the qualitative behaviors remain similar.
Additional features of the BMP pathway
The model above neglects a number of known features of the natural BMP pathway in order to focus on the specific effects of promiscuity, and to demonstrate its sufficiency for explaining observed computations. These other features are likely to play additional functional roles in the signaling pathway. One example is the dynamical nature of the receptor-ligand interactions, arising from receptor internalization, trafficking, and degradation. While the steady-state response studied in this paper is consistent with the BMP data, the parallel TGF-b branch of the pathway appears to respond transiently (adaptively) in some contexts (Warmflash et al., 2012) . Alternative models (Vilar et al., 2006; Zi et al., 2012) were previously developed that focused on these dynamical aspects of the TGF-b response, and showed how these dynamics can give rise to either transient or sustained responses, as well as absolute or relative ligand response profiles, although not the balance and imbalance detection modes described here.
Spatial heterogeneity
The plasma membrane has been shown to contain microdomains differing in lipid and protein composition, or interactions with the cytoskeleton, which could in principle affect spatial and temporal receptor distribution (Delos Santos et al., 2015) . This provokes the question of how receptor localization in microdomains could affect the computational behavior of the system. For example, a given receptor could be partially or completely segregated into certain domains which may or may not overlap with the localization of other receptors. Such effects can be modeled by replacing the existing affinity parameters with effective affinity parameters. Specifically, if two receptors are localized to completely different microdomains their effective affinity would be zero. By contrast, if they have a slight preference for distinct microdomains, their effective affinities would only be reduced. Representing domain preference this way provides two potential advantages for the system. First, it enables more flexibility in reaching diverse effective affinities among components. Second, if microdomain localization can be regulated by the cell, it can allow for dynamical tuning of effective affinity parameters, an additional mode of control.
QUANTIFICATION AND STATISTICAL ANALYSIS
Average and variability analysis All single cell flow cytometry data were averaged by taking the population median. Repeats were averaged by taking the mean of at least 3 repeats. Variability was assessed either using standard deviation or standard error of the mean, as indicated in the legend. To remove bias due to day-to-day variability we normalized each repeat by an overall scale factor. This was determined using total least square fit between each two experiments.
Assignment of integration modes in survey
In the survey (Figure 2A ), for each ligand pair, (L 1 , L 2 ), five different combinations ( Figure S1G) were measured: L 1 , L 2 , L 1 +L 2 , L 1 +L 1 , L 2 +L 2 , where the latter two indicate double the base concentration of a single ligand. Of these 5 combinations, the first three were assayed four times each, while the latter 2 were measured in duplicate. To estimate the relative likelihood of each ligand integration mode (Types I-IV in Figure S1G ), we examined all 256 possible measurement combinations. For each one, we determined the corresponding integration mode based on the classification scheme in Figure S1G . The relative likelihoods were then estimated by calculating the frequency of each integration mode. This is plotted in Figure S1H , as shown in the inset.
RNaseq Analyses
Total RNA was collected from cells using the RNeasy Mini Kit (QIAGEN) following the manufacturer's instructions. Sequencing libraries were constructed using NEBNext Ultra RNA-seq kit (NEB #E7530) and sequenced on Illumina HiSeq2500. Results were then analyzed using the web-based Galaxy platform (https://usegalaxy.org/). Alignment was performed using the TopHat algorithm followed by transcript assembly and FPKM estimates using the Cufflinks algorithm.
DATA AND SOFTWARE AVAILABILITY
Flow cytometry data was analyzed in MATLAB using a custom software (EasyFlow). Mathematical model simulations were performed and analyzed in MATLAB. All the analysis code is available upon request (see Contact for Reagent and Resource Sharing).
The RNAseq data reported in this paper have been deposited with the accession number GEO: GSE98674. 1000 ng/ml 250 ng/ml 62.5 ng/ml 15.6 ng/ml 3.90 ng/ml 0.97 ng/ml 0.24 ng/ml 0 ng/ml (A) For each ligand pair, experimentally measured pathway activity is plotted across all points in the ligand matrix, as a function of either the adjusted ratio of the two ligand concentrations (upper plot) or the sum of the two ligand concentrations (lower plot). Most of the variation in activity in BMP4-BMP9 can be explained by the sum of the two ligands (left plots). For BMP4-GDF5, the data are better explained as a function of an adjusted ratio, where the GDF5 concentration was offset by a constant, representing the threshold above which the response becomes approximately ratiometric. For BMP4-BMP10, the response approximately follows a non-monotonic function of the ratio. (B) Similar plots for the archetypes were generated in the model. (C) An independent BRE-based sensor cell line was generated from NMuMG using a different integration technique (PiggyBac, STAR Methods). It was exposed to the same BMP ligand pairs, giving rise to similar combined responses (cf. Figures 2C-2E ). (D) Ligands acquired from a different source (Peprotech, STAR Methods), show similar responses to those acquired from R&D Systems (cf. Figures 2D and 2E) . (E and F) Phosphorylated SMAD1/5/8 was analyzed using immunoblotting in cells exposed to single ligand, ligand combinations, or no ligand. BMP4 and BMP10 exhibited imbalance detection (E) , while BMP4 and GDF5 exhibited a ratiometric response (F) .
Supplemental Figures
(G) ERK phosphorylation in response to BMP ligands was analyzed using immunoblotting. While both ERK1 and ERK2 respond dose-dependently to EGF1, they show no response to BMP4, BMP10 and GDF5. In (E)-(G), results are normalized to the un-activated condition, and represent the mean and SD of at least 3 independent repeats. (C-E) SMAD6 knockdown does not disrupt ligand integration. The input-output response is plotted for cells treated with siRNA against Smad6 (siSmad6) or with a random sequence (siRND) (C) . qPCR analysis shows that siRNA treatment reduced Smad6 transcript by 90% (D) . Error bars indicate SD calculated from three independent experimetns. The results with siRNA for Smad6 were plotted against those with a random siRNA sequence (E) . Each dot represents a single ligand combination. Different colors represent different ligand pairs and the black line represents the line y = x for reference.
(F) Cells were stimulated with BMP9 and BMPR2 protein levels were measured at several time points after stimulation using immunoblotting. BMPR2 protein levels were normalized by GAPDH protein levels and the fold change from t = 0 was plotted. Error bars represent SD between 3 independent repeats. (G-J) The role of HSPGs was analyzed by inhibiting its biosynthesis using NaClO 3 (G) or by enzymatically removing HSPG using heparinase (H). Results with and without treatment show a high level of correlation around the line y = x plotted in black in (I) and (J). A) Different biochemical parameter sets generate a range of 2-ligand integration functions. Here, we plotted the steady-state response for 50 randomly selected parameter sets (grid of heatmaps). These responses are not organized spatially. Note the broad range of behaviors and the general dependence on ratiometric features at high total ligand concentrations, reflected by the diagonal contours. (B) 2-ligand response profiles can be parameterized by Relative Ligand Strength (RLS) and Ligand Interference Coefficient (LIC). These coefficients are determined by four activity levels that can be extracted from the high total ligand regime: the activity generated by the weaker (a) and stronger (b) ligands individually, as well as the maximal (c) and minimal (d) activity over the entire high ligand region, denoted by satmax and satmin, respectively. (C and D) Determination of RLS and LIC for balance (C) and imbalance (D) detection. (E) For each (LIC,RLS) coordinate pair, we computed the mean response functions for 5 biochemical parameter sets generating phenotypic parameters close to the indicated (LIC, RLS) point (location of heatmap). Inset zooms in on one specific (RLS,LIC) point. (F and G) Activity parameters can produce distinct response profiles from the same set of affinity parameters. (F) For a specific set of K ij ; K ijk values, indicated, the level of each trimeric signaling complex, T ijk , is plotted as a function of the concentrations of two ligands. (G) The total pathway response depends in general on the levels of all trimeric complexes, each multiplied by a corresponding activity parameter. Here we plot 4 specific sets of activities ðε ijk Þ, each of which generates a distinct response profile, despite using the same affinity parameters.
Ligand Interference Coefficient
Ligand Interference Coefficient Figures S4B-S4D) show similar distributions and produce all computations in both cases. (B) Parameter sets corresponding to the 4 archetypes were selected and the full 2D input-output matrices are plotted for models with (center) and without (left) ligand consumption. The difference (right column) between the two models (constant ligand, left, versus consumed ligand, middle) demonstrate that the effects of ligand consumption are most significant at intermediate ligand levels, giving rise to a sharper signal response. (C and D) 100,000 parameter sets were randomly selected either from the complete theoretically available parameter space, assuming a uniform distribution for the dimensionally reduced parameters (C) or from a biologically relevant range, based on previously measured values for BMP affinities (STAR Methods) (D) . Resulting response profiles are plotted in the RLS-LIC space (see Figure S4 ). Specific regions in the neighborhood of each archetype are shown (colored boxes). (E) The percent of parameter sets giving rise to each response type is shown for the unrestricted parameter selection (black) and for parameters restricted to the biologically relevant range (gray). To estimate uncertainty, we calculated SD between 10,000 bootstrapped samples of size 100,000.
Ligand2
Ligand 1 P P P P P P P P P P P P P P For each archetypal computation (rows), the left-hand schematic represents a parameter regime sufficient for the computation (re-plotted from Figures 5A-5D ). Arrow thicknesses represent the relative affinities or activities of indicated complexes. Arrow color represents the identity of the ligand in a given complex. To the right, the response profile across ligand compositions is shown (plot). The behavior of the system is also indicated schematically above the plot for three ligand composition regimes: only one ligand present (left and right) or an equal mixture of ligands (center). Hollow ligands represent those not present in each case. In each regime, some reactions do not occur (because a particular ligand is not present) or are disfavored (because of competition). Arrows for these reactions are omitted in the corresponding regimes. The total activity of the system in each of these three regimes is indicated by the number of copies of the phosphorylated second messenger. 
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